Indo Us Biotech Limited — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

The company has submitted a certificate under SEBI regulations to confirm compliance. This move demonstrates the company’s commitment to maintaining transparency and adherence to market standards. It underscores operational diligence, which may bolster investor confidence and enhance the company's reputation among stakeholders. While this update has a neutral impact on financial metrics, it reflects the company's dedication to governance and operational integrity, potentially paving the way for improved investor sentiment and a positive outlook.